On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Chemotherapy-induced organ toxicity mitigation

TopicLeading institutions, researchers & key papers

Chemotherapy-induced organ toxicity mitigation is a topic indexed in ScholarIQ from OpenAlex.

What is known about Chemotherapy-induced organ toxicity mitigation?

ScholarIQrecord summary

This cluster of papers focuses on the mechanisms of cisplatin-induced nephrotoxicity, including oxidative stress, apoptosis, inflammation, and mitochondrial dysfunction. It also explores various renoprotective strategies and potential interventions to mitigate kidney injury caused by cisplatin. The research covers a wide range of topics such as the role of specific antioxidants, inflammatory pathways, and cellular mechanisms involved in chemotherapy-induced kidney damage.

How many works does Chemotherapy-induced organ toxicity mitigation have?

ScholarIQindexed works

Chemotherapy-induced organ toxicity mitigation has 107 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Chemotherapy-induced organ toxicity mitigation?

ScholarIQopenalex

The OpenAlex for Chemotherapy-induced organ toxicity mitigation is on the source record.

What are the most-cited papers on Chemotherapy-induced organ toxicity mitigation?

ScholarIQmost cited works
Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro
Ying Zhou, Huitao Xu, Wenrong Xu, Bingying Wang, Huiyi Wu, Yang Tao, Bin Zhang, Mei Wang, Fei Mao, Yongmin Yan, Shuo Gao, Hongbing Gu, Wei Zhu, Hui Qian
Stem Cell Research & Therapy. 2013671 CitationsOPEN ACCESS
Cisplatin-Associated Nephrotoxicity and Pathological Events
Takashi Taguchi, Arifa Nazneen, M. Ruhul Abid, Mohammed S. Razzaque
Contributions to nephrology. 2005259 Citations
Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death
Kazuhiko Tsuruya, Toshiharu Ninomiya, Masanori Tokumoto, Makoto Hirakawa, Kohsuke Masutani, Masatomo Taniguchi, Kyoichi Fukuda, Hidetoshi Kanai, Kenji Kishihara, Hideki Hirakata, Mitsuo Iida
Kidney International. 2003242 Citations
Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure
Didier Portilla, Gonghe Dai, Timothy McClure, Linda M. Bates, Richard C. Kurten, Judit Megyesi, Peter M. Price, Shenyang Li
Kidney International. 2002143 CitationsOPEN ACCESS

Where is Chemotherapy-induced organ toxicity mitigation research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Chemotherapy-induced organ toxicity mitigation is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
40%
Green
0%
Hybrid
13%
Bronze
7%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial